188527-03-9

Basic information

• Product Name: tert-butyl 4-(4-bromophenylthio)piperidine-1-carboxylate
• Synonyms: tert-butyl 4-(4-bromophenylthio)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-[(4-broMophenyl)thio]-, 1,1-diMethylethyl ester;tert-butyl 4-(4-bromophenyl)sulfanylpiperidine-1-carboxylate
• CAS NO: 188527-03-9
• Molecular Formula: C₁₆H₂₂BrNO₂S
• Molecular Weight: 372.32038
• Mol File: 188527-03-9.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 4-(4-bromophenylthio)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(4-bromophenylthio)piperidine-1-carboxylate(188527-03-9)
• EPA Substance Registry System: tert-butyl 4-(4-bromophenylthio)piperidine-1-carboxylate(188527-03-9)

Safety Data

• Hazardous Substances Data: 188527-03-9(Hazardous Substances Data)

Usage

General Description

Tert-butyl 4-(4-bromophenylthio)piperidine-1-carboxylate is a chemical compound with a molecular formula C17H24BrNO2S. It is an ester derivative of piperidine, containing a tert-butyl group and a 4-(4-bromophenylthio) substituent. tert-butyl 4-(4-bromophenylthio)piperidine-1-carboxylate has potential applications in the field of organic chemistry, pharmaceuticals, and agrochemicals. It may be used as an intermediate in the synthesis of various bioactive molecules and drug candidates. The specific properties and uses of this compound may vary depending on the context and the desired applications.

Upstream product

• 911410-37-2 1-(4-hydroxypiperidin-1-yl)-2,2-dimethylpropan-1-one 
• 24424-99-5 di-tert-butyl dicarbonate 
• 5382-16-1 4-HYDROXYPIPERIDINE 
• 106-53-6 para-bromobenzenethiol 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 141699-59-4 1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate 

Downstream Products

• 797750-44-8 4-(4-cyanobenzenesulfonyl)piperidine-1-carboxylic acid tert-butyl ester 
• 1450723-99-5 C₁₂H₁₄N₂O₂S 
• 1450724-00-1 4-(1-acetylpiperidine-4-sulfonyl)benzonitrile 
• 1450724-01-2 C₁₅H₁₈N₂O₃S 
• 1450724-04-5 C₁₅H₁₈N₂O₃S 
• 1450724-05-6 4-[1-(tetrahydropyran-4-yl)piperidine-4-sulfonyl]benzonitrile 
• 1450724-02-3 C₁₃H₁₆N₂O₂S 
• 1450724-03-4 C₁₅H₂₀N₂O₂S 
• 1450723-87-1 C₁₃H₂₀N₂O₂S 
• 1450723-88-2 C₁₅H₂₄N₂O₂S 
• 1450723-34-8 N-[[4-(4,4-difluorocyclohexyl)sulfonylphenyl]methyl]-1,3-dihydropyrrolo[3,4-c]pyridine-2-carboxamide 
• 1450724-22-7 C₂₀H₂₃N₃O₆S 
• 1450724-23-8 C₂₂H₂₇N₃O₆S 
• 1450723-38-2 N-[[4-[(1-acetyl-4-piperidyl)sulfonyl]phenyl]methyl]-1,3-dihydropyrrolo[3,4-c]pyridine-2-carboxamide 

Relevant articles and documents

Synthesis and Characterization of N-(4-(Piperidin-4-ylsulfonyl) phenyl)5-vinylpyrimidin-2-amine

Target product N-(4-(piperidin-4-ylsulfonyl)phenyl)5-vinylpyrimidin-2- amine (13) was synthesized using 6-oxopyran-3-carbaldehyde (M1) and 4-hydroxypiperidine (M2) as starting materials by a series of nucleophilic substitution and oxidation. Different aci

AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES

The present invention relates to certain amido-benzyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.

THIAZOLE INHIBITORS TARGETING RESISTANT AND KINASE MUTATIONS

A compound is provided, having the general structure (A): wherein A is an aryl or heteroaryl group, Y is a hydrophobic linking moiety, and L is a substitutent. The compound (A) can be used for treatment of various angiogenic-associated or hematologic disorders, such as myeloproliferative disorders in patients who do not respond to kinase-inhibition therapy that comprises administering currently used medications.